litlas
ログインアカウント作成

Lars Rejnmark

1998–2025 年に発表

138
論文数
18,603
被引用数
81
h 指数
131
i10 指数

被引用数

Lars Rejnmark の年別被引用数1999 年: 被引用 1 件2000 年: 被引用 5 件2001 年: 被引用 4 件2002 年: 被引用 7 件2003 年: 被引用 9 件2004 年: 被引用 29 件2005 年: 被引用 54 件2006 年: 被引用 47 件2007 年: 被引用 68 件2008 年: 被引用 97 件2009 年: 被引用 75 件2010 年: 被引用 94 件2011 年: 被引用 86 件2012 年: 被引用 99 件2013 年: 被引用 120 件2014 年: 被引用 134 件2015 年: 被引用 155 件2016 年: 被引用 176 件2017 年: 被引用 174 件2018 年: 被引用 185 件2019 年: 被引用 598 件2020 年: 被引用 830 件2021 年: 被引用 598 件2022 年: 被引用 379 件2023 年: 被引用 261 件2024 年: 被引用 572 件2025 年: 被引用 342 件2026 年: 被引用 7 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,258 件、この内訳の 18.7%イギリス: 引用元論文 567 件、この内訳の 8.4%イタリア: 引用元論文 445 件、この内訳の 6.6%中国: 引用元論文 386 件、この内訳の 5.7%デンマーク: 引用元論文 344 件、この内訳の 5.1%カナダ: 引用元論文 284 件、この内訳の 4.2%ドイツ: 引用元論文 260 件、この内訳の 3.9%オーストラリア: 引用元論文 241 件、この内訳の 3.6%フランス: 引用元論文 225 件、この内訳の 3.3%オランダ: 引用元論文 210 件、この内訳の 3.1%スイス: 引用元論文 182 件、この内訳の 2.7%スペイン: 引用元論文 178 件、この内訳の 2.7%
0%18.7%その他 32%

機関

分野

  • Medicine81.8%
  • Biochemistry, Genetics and Molecular Biology9.3%
  • Neuroscience2.9%
  • Nursing1.9%
  • Engineering0.8%
  • Health Professions0.8%
  • その他2.5%

トピック

  • Vitamin D Research Studies9.2%
  • Bone health and osteoporosis research8.9%
  • Parathyroid Disorders and Treatments6.1%
  • Bone health and treatments3.6%
  • Thyroid and Parathyroid Surgery3.2%
  • Vitamin C and Antioxidants Research2.6%
  • その他66.4%

共著者

全論文

検索で開く
  1. Evaluation and Management of Hypoparathyroidism Summary Statement and Guidelines from the Second International Workshop

    著者: Aliya Khan, John P. Bilezikian, Maria Luisa Brandi, B.L. Clarke, Neil Gittoes, Janice L. Pasieka, Lars Rejnmark, Dolores Shoback, John T. Potts, Gordon Guyatt, Michael Mannstadt - Journal of Bone and Mineral Research 2020 被引用: 155

  2. Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia

    著者: Dieter Haffner, Francesco Emma, Deborah M. Eastwood, Martin Biosse Duplan, Justine Bacchetta, Dirk Schnabel, Philippe Wicart, Detlef Böckenhauer, Fernando Santos, Elena Levtchenko, Pol Harvengt, Martha Kirchhoff, Federico Di Rocco, Catherine Chaussain, Maria Luisa Brandi, Lars Sävendahl, Karine Briot, Peter Kamenický, Lars Rejnmark, Agnès Linglart - Nature Reviews Nephrology 2019 被引用: 532

  3. Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial

    著者: Louise Lind Schierbeck, Lars Rejnmark, Charlotte Landbo Tofteng, Lis Stilgren, Pia Eiken, L Mosekilde, Lars Køber, Jens‐Erik Beck Jensen - BMJ 2012 被引用: 738

  4. European expert consensus on practical management of specific aspects of parathyroid disorders in adults and in pregnancy: recommendations of the ESE Educational Program of Parathyroid Disorders (PARAT 2021)

    著者: Jens Bollerslev, Lars Rejnmark, Alexandra Zahn, Ansgar Heck, Natasha M Appelman-Dijkstra, Luis Cardoso, Fadil M Hannan, Filomena Cetani, Tanja Sikjaer, Anna Maria Formenti, Sigridur Björnsdottir, Camilla Schalin-Jäntti, Zhanna Belaya, Fraser Gibb, Bruno Lapauw, Karin Amrein, Corinna Wicke, Corinna Grasemann, Michael Krebs, Eeva Ryhänen, Özer Makay, Salvatore Minisola, Sébastien Gaujoux, Jean-Philippe Bertocchio, Zaki Hassan-Smith, Agnès Linglart, Elizabeth M Winter, Martina Kollmann, Hans-Georg Zmierczak, Elena Tsourdi, Stefan Pilz, Heide Siggelkow, Neil Gittoes, Claudio Marcocci, Peter Kamenický, _ _, Zillikens Carola, Frost Morten, Rolighed Lars, Sitges-Serra Antonio, Corbetta Sabrina, Decallonne Brigitte, Gherlan Iuliana, Gianotti Laura, Grigorie Daniel, Hindié Elif, Kiely Mairead, Lindner Kirsten, Makras Polyzois, Obermayer-Pietsch Barbara, R Perez-Lopez Fastino, Pretorius Mikkel, Saponaro Federica, Trummer Christian, Vamvakidis Kyriakos, Vashakmadze Natia, P Yavropoulou Maria - European Journal of Endocrinology 2021 被引用: 201

  5. Efficacy and Safety of Parathyroid Hormone Replacement With TransCon PTH in Hypoparathyroidism: 26-Week Results From the Phase 3 PaTHway Trial

    著者: Aliya Khan, Mishaela R. Rubin, Peter Schwarz, Tamara Vokes, Dolores Shoback, Claudia Gagnon, Andrea Palermo, Claudio Marcocci, B.L. Clarke, Lisa G Abbott, Lorenz C. Hofbauer, Lynn Kohlmeier, Susanne Pihl, Xuebei An, Walter Frank Eng, Alden Smith, Jenny Ukena, Christopher T. Sibley, Aimee D Shu, Lars Rejnmark - Journal of Bone and Mineral Research 2020 被引用: 97

  6. Cardiovascular and renal complications to postsurgical hypoparathyroidism: A Danish nationwide controlled historic follow-up study

    著者: Line Underbjerg, Tanja Sikjær, Leif Mosekilde, Lars Rejnmark - Journal of Bone and Mineral Research 2013 被引用: 310

  7. Rationale and Plan for Vitamin D Food Fortification: A Review and Guidance Paper

    著者: Stefan Pilz, Winfried März, Kevin D. Cashman, Máiréad Kiely, Susan J. Whiting, Michael F. Holick, William B. Grant, Paweł Płudowski, Mickaël Hiligsmann, Christian Trummer, Verena Theiler‐Schwetz, Elisabeth Lerchbaum, Marlene Pandis, Andreas Tomaschitz, Martin Grübler, Martin Gaksch, Nicolas Verheyen, Bruce W. Hollis, Lars Rejnmark, Spyridon Ν. Karras, Andreas Hahn, Heike A. Bischoff‐Ferrari, Jörg Reichrath, Rolf Jorde, Ibrahim Elmadfa, Reinhold Vieth, Robert Scragg, Mona S. Calvo, Natasja M. van Schoor, Roger Bouillon, Paul Lips, Suvi T. Itkonen, Adrian R. Martineau, Christel Lamberg‐Allardt, Armin Zittermann - Frontiers in Endocrinology 2018 被引用: 356

  8. European Society of Endocrinology Clinical Guideline: Treatment of chronic hypoparathyroidism in adults

    著者: Jens Bollerslev, Lars Rejnmark, Claudio Marcocci, Dolores Shoback, Antonio Sitges‐Serra, Wim Van Biesen, Olaf M Dekkers - European Journal of Endocrinology 2015 被引用: 454

  9. Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus

    著者: Aliya Khan, David A. Hanley, René Rizzoli, Jens Bollerslev, J. E. M. Young, Lars Rejnmark, Rajesh V. Thakker, P D'Amour, Terri Paul, Stan Van Uum, M. Zakaria Shrayyef, David Goltzman, S. Kaiser, Natalie E. Cusano, Roger Bouillon, Leif Mosekilde, A W Kung, Sudhaker D. Rao, Sanjay Kumar Bhadada, B.L. Clarke, Jue Liu, Quan‐Yang Duh, E. Michael Lewiecki, Francisco Bandeira, Richard Eastell, Claudio Marcocci, Shonni J. Silverberg, Robert Udelsman, K. Shawn Davison, John T. Potts, Maria Luisa Brandi, John P. Bilezikian - Osteoporosis International 2016 被引用: 538

  10. Vitamin D and mortality: Individual participant data meta-analysis of standardized 25-hydroxyvitamin D in 26916 individuals from a European consortium

    著者: Martin Gaksch, Rolf Jorde, Guri Grimnes, Ragnar M. Joakimsen, Henrik Schirmer, Tom Wilsgaard, Ellisiv B. Mathiesen, Inger Njølstad, Maja‐Lisa Løchen, Winfried März, Marcus E. Kleber, Andreas Tomaschitz, Martin Grübler, Guðný Eiríksdóttir, Elías F. Guðmundsson, Tamara B. Harris, Mary Frances Cotch, Thor Aspelund, Vilmundur Guðnason, Femke Rutters, Joline W. J. Beulens, Esther van ‘t Riet, Giel Nijpels, Joost Dekker, Diana Grove‐Laugesen, Lars Rejnmark, Markus Busch, Gert Mensink, Christa Scheidt‐Nave, Michael Thamm, Karin M. A. Swart, Ingeborg A. Brouwer, Paul Lips, Natasja M. van Schoor, Christopher T. Sempos, Ramón Durazo-Arvizú, Zuzana Škrabáková, Kirsten G. Dowling, Kevin D. Cashman, Máiréad Kiely, Stefan Pilz - PLoS ONE 2017 被引用: 351

  11. Postsurgical Hypoparathyroidism—Risk of Fractures, Psychiatric Diseases, Cancer, Cataract, and Infections

    著者: Line Underbjerg, Tanja Sikjær, Leif Mosekilde, Lars Rejnmark - Journal of Bone and Mineral Research 2014 被引用: 259

  12. The Epidemiology of Nonsurgical Hypoparathyroidism in Denmark: A Nationwide Case Finding Study

    著者: Line Underbjerg, Tanja Sikjær, Leif Mosekilde, Lars Rejnmark - Journal of Bone and Mineral Research 2015 被引用: 243

  13. Hypoparathyroidism

    著者: Michael Mannstadt, John P. Bilezikian, Rajesh V. Thakker, Fadil Hannan, B.L. Clarke, Lars Rejnmark, Deborah M. Mitchell, Tamara Vokes, Karen K. Winer, Dolores Shoback - Nature Reviews Disease Primers 2017 被引用: 211

  14. Management of Hypoparathyroidism

    著者: Aliya Khan, Gordon Guyatt, Dalal S. Ali, John P. Bilezikian, Michael T. Collins, Karel Dandurand, Michael Mannstadt, Deborah Murphy, Iman M’Hiri, Mishaela R. Rubin, Robert Sanders, Muhammad Shrayyef, Heide Siggelkow, Gaia Tabacco, Donovan Tay, Stan Van Uum, Tamara Vokes, Karen K. Winer, Liang Yao, Lars Rejnmark - Journal of Bone and Mineral Research 2020 被引用: 76

  15. PaTH Forward: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of TransCon PTH in Adult Hypoparathyroidism

    著者: Aliya Khan, Lars Rejnmark, Mishaela R. Rubin, Peter Schwarz, Tamara Vokes, B.L. Clarke, Intekhab Ahmed, Lorenz C. Hofbauer, Claudio Marcocci, Uberto Pagotto, Andrea Palermo, Erik Fink Eriksen, Meryl Brod, Denka Markova, Alden Smith, Susanne Pihl, Sanchita Mourya, David Karpf, Aimee D Shu - The Journal of Clinical Endocrinology & Metabolism 2021 被引用: 69

  16. Hypoparathyroidism in the adult: Epidemiology, diagnosis, pathophysiology, target-organ involvement, treatment, and challenges for future research

    著者: John P. Bilezikian, Aliya Khan, John T. Potts, Maria Luisa Brandi, B.L. Clarke, Dolores Shoback, Harald Jüppner, P D'Amour, John Fox, Lars Rejnmark, Leif Mosekilde, Mishaela R. Rubin, David W. Dempster, Rachel I. Gafni, Michael T. Collins, J. Sliney, James M. Sanders - Journal of Bone and Mineral Research 2011 被引用: 616

  17. Benefits and safety of dietary protein for bone health—an expert consensus paper endorsed by the European Society for Clinical and Economical Aspects of Osteopororosis, Osteoarthritis, and Musculoskeletal Diseases and by the International Osteoporosis Foundation

    著者: René Rizzoli, Emmanuel Biver, J.‐P. Bonjour, Véronique Coxam, David Goltzman, J. A. Kanis, Joan M. Lappe, Lars Rejnmark, Shivani Sahni, Connie M. Weaver, Hope A. Weiler, Jean‐Yves Reginster - Osteoporosis International 2018 被引用: 156

  18. Relative fracture risk in patients with diabetes mellitus, and the impact of insulin and oral antidiabetic medication on relative fracture risk

    著者: Peter Vestergaard, Lars Rejnmark, Leif Mosekilde - Diabetologia 2005 被引用: 558

  19. Hip Fracture Patients at Risk of Second Hip Fracture: A Nationwide Population-Based Cohort Study of 169,145 Cases During 1977–2001

    著者: Jesper Ryg, Lars Rejnmark, Søren Overgaard, Kim Brixen, Peter Vestergaard - Journal of Bone and Mineral Research 2009 被引用: 293

  20. Expression of vitamin D-metabolizing enzymes in human adipose tissue—the effect of obesity and diet-induced weight loss

    著者: Louise Wamberg, Terkel Christiansen, Søren K. Paulsen, Sanne Fisker, Peter Rask, Lars Rejnmark, Bjørn Richelsen, Steen B. Pedersen - International Journal of Obesity 2012 被引用: 253

  21. A Functional Amino Acid Substitution in the Glucose-Dependent Insulinotropic Polypeptide Receptor (GIPR) Gene Is Associated With Lower Bone Mineral Density and Increased Fracture Risk

    著者: Signe S. Torekov, Torben Harsløf, Lars Rejnmark, Pia Eiken, Jens‐Erik Beck Jensen, Amir Herman, Torben Hansen, Oluf Pedersen, Jens J. Holst, Bente Langdahl - The Journal of Clinical Endocrinology & Metabolism 2014 被引用: 107

  22. Vitamin D and Muscle Health: A Systematic Review and Meta-analysis of Randomized Placebo-Controlled Trials

    著者: Lise Sofie Bislev, Diana Grove‐Laugesen, Lars Rejnmark - Journal of Bone and Mineral Research 2020 被引用: 71

  23. Risk of Chronic Kidney Disease and Estimated Glomerular Filtration Rate Decline in Patients with Chronic Hypoparathyroidism: A Retrospective Cohort Study

    著者: Elvira O. Gosmanova, Kristina Chen, Lars Rejnmark, Fan Mu, Elyse Swallow, Allison Briggs, Olulade Ayodele, Nicole Sherry, Markus Ketteler - Advances in Therapy 2021 被引用: 47

  24. Diabetes and Its Complications and Their Relationship with Risk of Fractures in Type 1 and 2 Diabetes

    著者: Peter Vestergaard, Lars Rejnmark, Leif Mosekilde - Calcified Tissue International 2008 被引用: 282